AAM
RPTP

Alpine Associates Management’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Alpine Associates Management’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-3,804,600
Closed -$34.1M – 89
2016
Q3 		$34.1M Buy
+3,804,600
New +$27.1M 1.25% 29

Alpine Associates Management's RPTP Position: Q4 2016 in Review

Alpine Associates Management sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 3,804,600 shares — an estimated $34.1M sold.

Alpine Associates Management first reported a position in RPTP in Q3 2016 and held it in 1 quarter. The position peaked at $34.1M in Q3 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • Alpine Associates Management reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • Alpine Associates Management sold 3,804,600 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $34.1M.
  • Alpine Associates Management first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2016 and held it in 1 quarter.
  • Alpine Associates Management's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $34.1M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Alpine Associates Management's 13F filing for Q4 2016, filed 13 Feb 2017.